Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mangold

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2001
Pharmacokinetics and metabolism of nateglinide in humansM L Weaver, B A Orwig, L C Rodriguez, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 11, 2014
Physiologically based pharmacokinetic modeling for assessing the clinical drug-drug interaction of alisporivirBinfeng Xia, Avantika Barve, Tycho Heimbach, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 3, 2016
Disposition and metabolism of [(14)C] Sacubitril/Valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjectsJimmy Flarakos, Yancy Du, Timothy Bedman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2016
KAE609 (Cipargamin), a New Spiroindolone Agent for the Treatment of Malaria: Evaluation of the Absorption, Distribution, Metabolism, and Excretion of a Single Oral 300-mg Dose of [14C]KAE609 in Healthy Male SubjectsSu-Er W Huskey, Chun-qi Zhu, Andreas Fredenhagen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2016
Identification of Three Novel Ring Expansion Metabolites of KAE609, a New Spiroindolone Agent for the Treatment of Malaria, in Rats, Dogs, and HumansSu-Er W Huskey, Chun-qi Zhu, Melissa M Lin, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 9, 2016
Clinical disposition, metabolism and in vitro drug-drug interaction properties of omadacyclineJimmy Flarakos, Yancy Du, Helen Gu, et al.
Antimicrobial Agents and Chemotherapy|August 17, 2002
N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activityCorinne J Hackbarth, Dawn Z Chen, Jason G Lewis, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2001
Pharmacokinetics and metabolism of nateglinide in humansM L Weaver, B A Orwig, L C Rodriguez, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 11, 2014
Physiologically based pharmacokinetic modeling for assessing the clinical drug-drug interaction of alisporivirBinfeng Xia, Avantika Barve, Tycho Heimbach, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 3, 2016
Disposition and metabolism of [(14)C] Sacubitril/Valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjectsJimmy Flarakos, Yancy Du, Timothy Bedman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2016
KAE609 (Cipargamin), a New Spiroindolone Agent for the Treatment of Malaria: Evaluation of the Absorption, Distribution, Metabolism, and Excretion of a Single Oral 300-mg Dose of [14C]KAE609 in Healthy Male SubjectsSu-Er W Huskey, Chun-qi Zhu, Andreas Fredenhagen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2016
Identification of Three Novel Ring Expansion Metabolites of KAE609, a New Spiroindolone Agent for the Treatment of Malaria, in Rats, Dogs, and HumansSu-Er W Huskey, Chun-qi Zhu, Melissa M Lin, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 9, 2016
Clinical disposition, metabolism and in vitro drug-drug interaction properties of omadacyclineJimmy Flarakos, Yancy Du, Helen Gu, et al.
Antimicrobial Agents and Chemotherapy|August 17, 2002
N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activityCorinne J Hackbarth, Dawn Z Chen, Jason G Lewis, et al.
Pageof 8